Novartis

Results: 1795



#Item
31

Ausschreibung NOVARTIS-PREIS FÜR THERAPIERELEVANTE PHARMAKOLOGISCHE FORSCHUNG Pharmakologische Grundlagenforschung und klinische Anwendung von Arzneimitteln gehören eng zusammen, wenn die jeweiligen Forschungsaktivitä

Add to Reading List

Source URL: www.dgpt-online.de

- Date: 2016-05-04 17:42:15
    32

    PRESSEINFORMATION Novartis Vaccines and Diagnostics ist 7.000stes GPM Mitglied Nürnberg, 3. Juli 2015 – Zuwachs für Deutschlands größtes Netzwerk für Projektmanager: Novartis Vaccines and Diagnostics GmbH ist das

    Add to Reading List

    Source URL: www.gpm-ipma.de

    - Date: 2015-07-03 06:03:06
      33Pharmaceutical sciences / Pharmacology / Business / Pharmaceutical industry / Pharmacy / Biotechnology / European Federation of Pharmaceutical Industries and Associations / Immunogenicity / Drug discovery / Novartis / Biopharmaceutical / Sanofi

      ABIRISK ABIRISK Project Officially Started A growing number of medicines are based on biological molecules such as proteins and monoclonal antibodies. These novel drugs have resulted in new, more effective treatments for

      Add to Reading List

      Source URL: www.abirisk.eu

      Language: English - Date: 2012-06-04 10:07:55
      34Business / Biotechnology / Economy / Pharmacy / Pharmaceutical industry / Pharmaceuticals policy / Biopharmaceutical / Pharmaceutical industry in India / Novartis / Biosimilar / Boehringer Ingelheim / Teva Pharmaceutical Industries

      January 8, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum. 1. Baxalta, Symphogen Ink $1.6 Billion Immuno­Oncology Deal In yet

      Add to Reading List

      Source URL: www.dcat.org

      Language: English - Date: 2016-01-11 11:16:23
      35Business / Economy / Novartis / Syngenta / Caterpillar Inc.

      IEBA International Employee Benefits Association IEBA–CH MEETING

      Add to Reading List

      Source URL: www.ieba.org.uk

      Language: English - Date: 2016-06-06 05:23:51
      36Chemistry / Organic chemistry / Angiotensin II receptor antagonists / Hypertension / Tetrazoles / Antihypertensive agents / Carboxylic acids / Imidazoles / Hydrochlorothiazide / Valsartan / Novartis / Aliskiren

      alternative to diovan what is generic for diovan. maker of diovan. buy diovan 320 mg, picture of 80 mg diovan pill, diovan generic alternatives diovan being pulled off the market diovan complaints footpain diovan, buying

      Add to Reading List

      Source URL: pulseseismic.com

      Language: English - Date: 2016-08-23 22:37:06
      37

      Microsoft Word - Novartis und der UNGC Forum-Wirtschaftsethik.docx

      Add to Reading List

      Source URL: www.globalewerteallianz.ch

      Language: German - Date: 2014-07-30 13:36:11
        38Health care / Health / Business / Pharmaceutical industry / European Federation of Pharmaceutical Industries and Associations / Pharmaceuticals policy / Clinical trials / Innovative Medicines Initiative / Pharmaceutical Research and Manufacturers of America / Pharmacovigilance / Novartis / EuropaBio

        EFPIA Annual Report 2015 @EFPIA Introduction

        Add to Reading List

        Source URL: www.efpia.eu

        Language: English - Date: 2016-06-15 04:09:40
        39Business / Economy / Biotechnology / CAC 40 / Sanofi / AstraZeneca / Novartis / Takeda Pharmaceutical Company / Valeant Pharmaceuticals / Pharmaceutical industry in China / Bausch & Lomb / Pharmaceutical industry in India

        February 5, 2016 BUSY WEEK? Here are the TOP INDUSTRY NEWS stories you might have missed, as selected by DCAT Editorial Director Patricia Van Arnum.  Sponsored By:

        Add to Reading List

        Source URL: www.dcat.org

        Language: English - Date: 2016-02-09 09:31:44
        40Economy / Ethics / Applied ethics / RTT / Novartis / Novartis Foundation / Artemether/lumefantrine / Business ethics / Social responsibility / Corporate social responsibility / Imatinib / Ciba

        Corporate Social Responsibility From the Novartis perspective Dr. Joerg Reinhardt Chairman Bern, June

        Add to Reading List

        Source URL: www.swissholdings.ch

        Language: English - Date: 2016-06-10 02:39:23
        UPDATE